Event Date
Conference / Lecture Topics
Location
| December 31, 2025 10:00-12:00 |
| December 12,2025 08:50-10:00 |
| November 26,2025 10:30-12:00 |
| November 22,2025 09:00-16:00 |
| October 03,2025 13:30-15:00 |
| August 16,2025 09:00-17:00 |
| July 26,2025 13:30-17:00 |
| April 9,2025 10:00-12:00 |
| March 22,2025 08:20-17:00 |
| March 8,2025 09:00-17:00 |
| November 9,2024 09:00-16:30 |
| Room 101, Shou-Ren Building, Yangming Campus,NYCU |
| Conference Room 320, Shou-Ren Building, Yangming Campus, NYCU |
| Conference Room 320, Shou-Ren Building, Yangming Campus, NYCU |
| Auditorium, Interdisciplinary Research Building, Academia Sinica |
| Conference Room 320, Shou-Ren Building, Yangming Campus, NYCU |
| Ying-Tsai Hall, Shou-Ren Building, Yangming Campus, NYCU |
| Meeting Room 402 (A+B), 4th Floor, Taipei Nangang Exhibition Center Hall 1 |
| Room 103, Shou-Ren Building, Yangming Campus, NYCU |
| Conference Room 101, College of Medicine Building, NTU |
| Second International Conference Hall, B1 Conference Area, General Medicine Building, Chiayi Chang Gung Memorial Hospital |
| First-Floor Auditorium, Interdisciplinary Research Building, Academia Sinica |
Publication Date
November 24,2024
Title
Congratulations to Professor Chun-Ying Wu and colleagues on the publication of “Automatic Localization and Deep Convolutional Generative Adversarial Network-Based Classification of Focal Liver Lesions in Computed Tomography Images: A Preliminary Study” in the Journal of Gastroenterology and Hepatology.
Abstract
This study developed a deep learning–based Liver Lesion Localization and Classification (DLLC) system designed to assist physicians in interpreting local liver lesions in CT images. The system achieved an average localization precision of 0.81 and a classification accuracy of 0.97, with an accuracy of 0.83 for lesions smaller than 3 cm and 0.87 for lesions larger than 3 cm. This system provides an accurate and non-invasive diagnostic approach, offering significant value to hepatologists and radiologists.
October 22,2024
July 30,2024
Congratulations to Associate Professor Li-Lin Liang and colleagues on the publication of “The Role of Digital Health Under Taiwan’s National Health Insurance System: Progress and Challenges” in Health Systems and Reform.
Digital health encompasses the application of digital technologies in the medical field, playing a crucial role in improving the accessibility, quality, and efficiency of healthcare services. This study examines digital health under Taiwan’s National Health Insurance, particularly its impact during the COVID-19 pandemic, focusing on big data management and analytics (such as MediCloud and My Health Bank/NHI Mobile Easy Access) as well as innovative service models (such as telemedicine). The study indicates that individuals with higher income and those with chronic or severe conditions are more likely to use telemedicine, and it highlights challenges related to digital trust and the digital divide.
This study investigated the effects of short-chain fatty acids (SCFAs) on skin phenotype, systemic inflammation, and gut microbiota in mice with psoriasis-like symptoms. Imiquimod (IMQ)-treated mice were used as the model, and genomic analyses were conducted to examine the impact of SCFAs or anti–IL-17 antibodies on skin thickness, inflammatory markers, and fecal microbiota. The results showed that SCFAs ameliorated IMQ-induced skin thickening, spleen enlargement, and serum IL-17F levels, with effects comparable to anti–IL-17 treatment. SCFAs also increased microbial diversity and altered gut microbiota composition, suggesting associations with carbohydrate degradation and phenylalanine metabolism.
